X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (101) 101
Patent (46) 46
Book Review (7) 7
Conference Proceeding (5) 5
Publication (4) 4
Book Chapter (1) 1
Dissertation (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (60) 60
humans (57) 57
female (50) 50
oncology (47) 47
arrangement or mounting of plural diverse prime-movers invehicles (46) 46
arrangement or mounting of propulsion units or oftransmissions in vehicles (46) 46
arrangements in connection with cooling, air intake, gasexhaust or fuel supply of propulsion units, in vehicles (46) 46
auxiliary drives for vehicles (46) 46
beer (46) 46
biochemistry (46) 46
chemistry (46) 46
compositions or test papers therefor (46) 46
condition-responsive control in microbiological orenzymological processes (46) 46
enzymology (46) 46
instrumentation or dashboards for vehicles (46) 46
measuring or testing processes involving enzymes, nucleicacids or microorganisms (46) 46
metallurgy (46) 46
microbiology (46) 46
mutation or genetic engineering (46) 46
performing operations (46) 46
processes of preparing such compositions (46) 46
spirits (46) 46
transporting (46) 46
vehicle suspension arrangements (46) 46
vehicles in general (46) 46
vinegar (46) 46
wine (46) 46
culture media (42) 42
compositions thereof (41) 41
microorganisms or enzymes (41) 41
propagating, preserving or maintaining microorganisms (41) 41
breast neoplasms - drug therapy (33) 33
middle aged (31) 31
adult (29) 29
breast cancer (28) 28
aged (27) 27
breast neoplasms - pathology (25) 25
cancer (14) 14
trastuzumab (14) 14
aged, 80 and over (13) 13
antineoplastic combined chemotherapy protocols - therapeutic use (13) 13
neoplasm metastasis (13) 13
antibodies, monoclonal, humanized (12) 12
antineoplastic agents - therapeutic use (11) 11
chemotherapy (11) 11
abridged index medicus (10) 10
breast neoplasms - genetics (10) 10
health aspects (10) 10
physics (10) 10
therapy (10) 10
antineoplastic agents - adverse effects (9) 9
combinatorial chemistry (9) 9
libraries, e.g. chemical libraries, in silicolibraries (9) 9
neoplasm staging (9) 9
treatment outcome (9) 9
antibodies, monoclonal - therapeutic use (8) 8
breast neoplasms - metabolism (8) 8
breast neoplasms - mortality (8) 8
calculating (8) 8
care and treatment (8) 8
computing (8) 8
counting (8) 8
electric digital data processing (8) 8
immunohistochemistry (8) 8
medicine, general & internal (8) 8
risk (8) 8
survival analysis (8) 8
women (8) 8
antibodies, monoclonal - administration & dosage (7) 7
antibodies, monoclonal - adverse effects (7) 7
bevacizumab (7) 7
disease progression (7) 7
medicine & public health (7) 7
mutation (7) 7
prognosis (7) 7
risk factors (7) 7
antineoplastic agents - administration & dosage (6) 6
breast neoplasms - therapy (6) 6
chemotherapy, adjuvant (6) 6
disease-free survival (6) 6
estrogen (6) 6
genetic aspects (6) 6
investigating or analysing materials by determining theirchemical or physical properties (6) 6
measuring (6) 6
phase-ii (6) 6
postmenopausal women (6) 6
quality of life (6) 6
safety (6) 6
testing (6) 6
antineoplastic combined chemotherapy protocols - adverse effects (5) 5
carcinoma (5) 5
colorectal-cancer (5) 5
drug therapy (5) 5
efficacy (5) 5
expression (5) 5
metastasis (5) 5
mutations (5) 5
ovarian-cancer (5) 5
patients (5) 5
plus (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 12/2007, Volume 357, Issue 26, pp. 2666 - 2676
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2019, Volume 37, Issue 15_suppl, pp. e12533 - e12533
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/2008, Volume 26, Issue 11, pp. 1810 - 1816
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 9/2019, Volume 177, Issue 2, pp. 325 - 333
The PI3K pathway, which includes the PI3K catalytic subunits p110α (PIK3CA) and the PI3K regulatory subunit p85α (PIK3R1), is the most frequently altered... 
MEK | Medicine & Public Health | Cellular signaling | Oncology | PIK3R1 | BREAST CANCER | Trametinib | EPITHELIAL-CELLS | GENE | ONCOLOGY | HIGH-FREQUENCY | PD-0325901 | MUTATIONS | PREVIOUSLY TREATED PATIENTS | Antimitotic agents | Carboplatin | Breast cancer | Genetic aspects | Drug therapy | Antineoplastic agents | Health aspects | Index Medicus
Journal Article
The Lancet Oncology, ISSN 1470-2045, 10/2017, Volume 18, Issue 10, pp. 1360 - 1372
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 10/2017, Volume 23, Issue 19, pp. 5687 - 5695
Journal Article
Journal Article